Therefore, we speculate that PKMYT1 might act as an oncogene in ccRC and its inhibition may play an antitumor role by inducing apoptosis, suggesting potential therapeutic avenues for the treatment of ccRCC for future study. Here, PKMYT1 is linked to nonpapillary renal cell carcinoma.